AstraZeneca PLC operates as a holding company. The Company, through its subsidiaries, researches, manufactures, and sells pharmaceutical and medical products. AstraZeneca focuses its operations on eight therapeutic areas, including gastrointestinal, oncology, cardiovascular, respiratory, central nervous system, pain control, anaesthesia, and infection.

Acquisition of Amolyt Pharma completed 

Total Voting Rights

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

AstraZeneca PLC (AZN LN)

Acquisition of Amolyt Pharma completed

Total Voting Rights

Lynparza & Imfinzi positive CHMP in endometrial

Update on Imfinzi ADJUVANT BR.31 trial

Imfinzi improved EFS and OS in bladder cancer

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)